Francisco J. Tinahones

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

José María Moreno‐Navarrete, Francisco Ortega, Marta Serrano et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 787 citations

Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study

Mora Murri, Isabel Leiva, Juan Miguel Gómez‐Zumaquero et al. · BMC Medicine · 2013 · 769 citations · Full text

Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers

María Isabel Queipo‐Ortuño, María Boto‐Ordóñez, Mora Murri et al. · American Journal of Clinical Nutrition · 2012 · 651 citations · Full text

Gut Microbiota Ecology, Red Wine Polyphenols, Dysbiosis +9

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9